Angiodynamics (ANGO) Return on Sales (2010 - 2026)

Angiodynamics' Return on Sales history runs 17 years deep, the most recent figure standing at 0.0% for Q2 2026.

• Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q2 2026, while the trailing twelve-month figure through May 2026 was 0.0% (changed 0.0% YoY) and the FY2026 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Sales was 0.0% for Q2 2026 at Angiodynamics, down from 0.0% in the prior quarter.
• Across five years, Return on Sales topped out at 0.01% in Q3 2023 and bottomed at 0.02% in Q1 2024.
• A 5-year average of 0.0% and a median of 0.0% in 2023 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2024 — Return on Sales slipped 2 bps — and 2025, when it grew 2 bps.
• Angiodynamics' Return on Sales stood at 0.0% in 2022, then tumbled by 270 bps to 0.0% in 2023, then surged by 60 bps to 0.0% in 2024, then jumped by 46 bps to 0.0% in 2025, then slumped by 65 bps to 0.0% in 2026.
• Business Quant data shows ANGO's Return on Sales at 0.0% in Q2 2026, 0.0% in Q1 2026, and 0.0% in Q4 2025.